-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Perspectives on the Treatment of DVT/PE, Including Those Patients with Obesity and/or Cancer

Sponsor: Janssen Pharmaceuticals, Inc
Program: Product Theaters
Monday, December 12, 2022: 8:00 AM-9:00 AM
Hall J - Theater 5 (Ernest N. Morial Convention Center)
Keturah Reid Robinson, PharmD, BCPS, LSSBB, Janssen Pharmaceuticals, Inc.
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters